Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

BVMF/PFRM3 stock hub

BVMF/PFRM3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/PFRM3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

879.1M

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/PFRM3

In the news

Latest news · BVMF/PFRM3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E8.4

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC12.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/PFRM3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

BRL

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	7,077
Employees Change	159%
Employees Change Percent	2.3
Enterprise value	BRL 2.5B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Medical Distribution
Isin	BRPFRMACNOR1
Last refreshed	2026-05-10
Market cap	BRL 879.1M
Price	BRL 7.17
Price currency	BRL
Rev Per Employee	1,641,079.98x
Sector	Healthcare
Sic	5122
Symbol	bvmf/PFRM3
Website	https://www.profarma.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12%
EV Earnings	23.25x
EV/EBIT	6.87x
EV/EBITDA	4.52x
EV/FCF	7.18x
EV/Sales	0.21x
FCF yield	38.86%
P/B ratio	0.54x
P/E ratio	8.37x
P/S ratio	0.08x
PE Ratio10 Y	13.03x
PE Ratio3 Y	9.17x
PE Ratio5 Y	8.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.07%
EBITDA Margin	3.58%
FCF margin	2.94%
Gross margin	15.42%
Gross Profit	BRL 1.8B
Gross Profit Growth	12.63%
Gross Profit Growth Q	10.21%
Gross Profit Growth3 Y	14.35%
Gross Profit Growth5 Y	18.12%
Net Income	BRL 105.5M
Net Income Growth	-15.31%
Net Income Growth Years	2%
Net Income Growth3 Y	8.7%
Net Income Growth5 Y	11.78%
Pretax Margin	0.95%
Profit Margin	0.91%
Profit Per Employee	BRL 14,905
Profitable Years	7
ROA	3.77
Roa5y	3.31
ROCE	12.64
ROE	7
Roe5y	6.38
ROIC	12.49
Roic5y	10.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.13%
Cagr15y	-2.51%
Cagr1y	-0.26%
Cagr3y	40.96%
Cagr5y	9.64%
Div CAGR10	16.63%
Div CAGR3	63.54%
Div CAGR5	22.88%
EPS Growth	-15.6
EPS Growth Years	2
EPS Growth3 Y	8.54
EPS Growth5 Y	11.68
FCF Growth	19.2%
FCF Growth3 Y	5.62%
OCF Growth	24.65%
OCF Growth Q	4,107.14%
OCF Growth3 Y	12.3%
OCF Growth5 Y	93.64%
Revenue Growth	9.43x
Revenue Growth Q	6.03x
Revenue Growth Quarters	31x
Revenue Growth Years	11x
Revenue Growth3 Y	12.82x
Revenue Growth5 Y	15.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 1.96
Assets	BRL 6B
Cash	BRL 316.5M
Current Assets	BRL 4.3B
Current Liabilities	BRL 3.2B
Debt	BRL 1.6B
Debt EBITDA	BRL 2.95
Debt Equity	BRL 0.98
Debt FCF	BRL 4.68
Equity	BRL 1.6B
Interest Coverage	1.61
Liabilities	BRL 4.4B
Long Term Assets	BRL 1.8B
Long Term Liabilities	BRL 1.2B
Net Cash	BRL -1.3B
Net Cash By Market Cap	BRL -146
Net Debt EBITDA	BRL 3.08
Net Debt Equity	BRL 0.79
Net Debt FCF	BRL 3.75
Tangible Book Value	BRL 702.6M
Tangible Book Value Per Share	BRL 5.62
WACC	9.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Inventory Turnover	5.4
Net Working Capital	BRL 1.3B
Quick ratio	0.71
Working Capital	BRL 1.1B
Working Capital Turnover	BRL 11.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.4%
Dividend Growth	31.83%
Dividend Growth Years	2%
Dividend per share	BRL 0.58
Dividend Years	6
Dividend Yield	8.02%
Ex Div Date	2026-01-02
Last Dividend	BRL 0.32
Payout Ratio	74.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	23.44%
1Y total return	-0.26%
200-day SMA	8.07
3Y total return	180.15%
50-day SMA	8.12
50-day SMA vs 200-day SMA	50over200
5Y total return	58.39%
All Time High	40.9
All Time High Change	-82.47%
All Time High Date	2007-02-02
All Time Low	2.87
All Time Low Change	149.83%
All Time Low Date	2020-03-23
ATR	0.34
Beta	0.43
Beta1y	-0.12
Beta2y	-0.01
Ch YTD	-21.47
High	7.29
High52	9.7
High52 Date	2026-01-29
High52ch	-26.08%
Low	7.01
Low52	6.62
Low52 Date	2025-10-22
Low52ch	8.31%
Ma50ch	-11.73%
Price vs 200-day SMA	-11.14%
RSI	36.49
RSI Monthly	48.58
RSI Weekly	41.23
Sharpe ratio	0.13x
Sortino ratio	0.33
Total Return	7.62%
Tr YTD	-18.63
Tr15y	-31.7%
Tr1m	-12.35%
Tr1w	-6.52%
Tr3m	-15.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 356.9M
Operating Income Growth	17.37
Operating Income Growth Q	13.85
Operating Income Growth3 Y	11.83
Operating Income Growth5 Y	24.04
Operating margin	3.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,389,355%
Net Borrowing	39,115,000
Shares Insiders	2.45%
Shares Institutions	5.62%
Shares Out	122,610,773
Shares Qo Q	1.95%
Shares Yo Y	0.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 341.6M
Average Volume	247,905x
Bv Per Share	10.73
CAPEX	BRL -152.1M
Ch10y	-12.56
Ch15y	-55.19
Ch1m	-12.35
Ch1w	-6.52
Ch1y	-7.48
Ch3m	-15.94
Ch3y	128.3
Ch5y	18.32
Ch6m	-10.82
Change	0.28%
Change From Open	-0.14
Close	7.15
Days Gap	0.42
Depreciation Amortization	58,838,000
Dollar Volume	1,123,539
Earnings Date	2026-05-06
EBIT	BRL 356.9M
EBITDA	BRL 415.8M
EPS	BRL 0.86
F Score	7
FCF	BRL 341.6M
FCF EV Yield	13.93x
FCF Per Share	BRL 2.79
Financing CF	-256,714,000
Fiscal Year End	December
Founded	1,961
Graham Number	14.38042
Graham Upside	100.6
Income Tax	BRL -3M
Investing CF	-186,361,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	BRL 10.09
Lynch Upside	40.7
Ma150	8.2
Ma150ch	-12.56%
Ma20	7.89
Ma20ch	-9.16%
Net CF	50,566,000
Next Earnings Date	2026-07-29
Open	7.18
P FCF Ratio	2.57
P OCF Ratio	1.78
Payment Date	2026-01-15
Position In Range	57.14
Ppne	842,583,000
Price Date	2026-05-08
Price EBITDA	BRL 2.11
Ptbv Ratio	1.25
Relative Volume	0.64x
Revenue	11,613,923,000x
Tax By Revenue	-0.03x
Tr6m	-5.72%
Volume	156,700

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/PFRM3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+8.0%

$0.57 annual per share

Payout ratio

+74.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+22.9%

2 consecutive years of growth

Total shareholder yield

+7.6%

Next ex-dividend date: 2026-01-02

Performance

BVMF/PFRM3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/PFRM3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.6%

Share of float held by funds and institutions

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

BVMF/PFRM3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.5

Neutral momentum band

Price vs 200-day MA

-11.1%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/PFRM3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/PFRM3 stock rating?

bvmf/PFRM3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/PFRM3 analysis?

The full report lives at /stocks/bvmf/PFRM3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/PFRM3?

The latest report frames bvmf/PFRM3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/PFRM3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.